PW Medtech Group Valuation Multiples
PW Medtech Group is valued at $162M as of November 2026, a 0.2x revenue multiple. In the last fiscal year, PW Medtech Group revenue was $124M and PW Medtech Group EBITDA was $39M.
PW Medtech Group Overview
About PW Medtech Group
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments namely Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.
Founded
2011
HQ
Employees
1.4K
Website
Financials (Last FY)
EV
$24M
Valuation Multiples
Start free trial
PW Medtech Group Financials
PW Medtech Group reported last fiscal year revenue of $124M and EBITDA of $39M.
In the same fiscal year, PW Medtech Group generated $61M in gross profit, $39M in EBITDA, and $14M in net income.
PW Medtech Group P&L
In the most recent fiscal year, PW Medtech Group reported revenue of $124M and EBITDA of $39M.
PW Medtech Group is profitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 32%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
PW Medtech Group Stock Performance
PW Medtech Group has current market cap of $162M, and enterprise value of $24M.
Market Cap Evolution
PW Medtech Group's stock price is $0.11.
PW Medtech Group share price increased by 0.1% in the last 30 days.
PW Medtech Group has an EPS (earnings per share) of $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $24M | $162M | 0.0% | 0.1% | - | - | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPW Medtech Group Valuation Multiples
PW Medtech Group trades at 0.2x EV/Revenue multiple, and 0.6x EV/EBITDA.
PW Medtech Group Financial Valuation Multiples
As of November 9, 2026, PW Medtech Group has market cap of $162M and EV of $24M.
PW Medtech Group has a P/E ratio of 11.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PW Medtech Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
PW Medtech Group Margins & Growth Rates
In the most recent fiscal year, PW Medtech Group reported gross margin of 49%, EBITDA margin of 32%, and net margin of 11%.
PW Medtech Group Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
PW Medtech Group Operational KPIs
PW Medtech Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
PW Medtech Group Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all PW Medtech Group competitors and their valuation data. Start Free Trial | ||||||
Investments by PW Medtech Group
PW Medtech Group has invested in 1 company to date.
Latest investment by PW Medtech Group was on August 24th 2018. PW Medtech Group invested in Taibang Biological Group in their $590M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by PW Medtech Group
| Description | Taibang Biological Group, operating as China Biologic Products Holdings, is a Jinan-headquartered biopharmaceutical company in Shandong Province manufacturing plasma-derived products including human albumin, immunoglobulin, and coagulation factors. It conducts plasma collection at stations across China and produces biologics for hospitals and clinics nationwide. |
| HQ Country | |
| HQ City | Beijing |
| Deal Date | 24 Aug 2018 |
| Round | Undisclosed stage |
| Raised | $590M |
| Investors | PW Medtech Group; Hillhouse Investment; Centurium Capital; CITIC Capital Holdings |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all PW Medtech Group investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PW Medtech Group
| When was PW Medtech Group founded? | PW Medtech Group was founded in 2011. |
| Where is PW Medtech Group headquartered? | PW Medtech Group is headquartered in China. |
| How many employees does PW Medtech Group have? | As of today, PW Medtech Group has over 1K employees. |
| Is PW Medtech Group publicly listed? | Yes, PW Medtech Group is a public company listed on HKEX. |
| What is the stock symbol of PW Medtech Group? | PW Medtech Group trades under 01358 ticker. |
| When did PW Medtech Group go public? | PW Medtech Group went public in 2013. |
| Who are competitors of PW Medtech Group? | PW Medtech Group main competitors include |
| What is the current market cap of PW Medtech Group? | PW Medtech Group's current market cap is $162M. |
| What is the current revenue of PW Medtech Group? | PW Medtech Group's last fiscal year revenue is $124M. |
| What is the current EV/Revenue multiple of PW Medtech Group? | Current revenue multiple of PW Medtech Group is 0.2x. |
| Is PW Medtech Group profitable? | No, PW Medtech Group is not profitable. |
| How many companies PW Medtech Group has acquired to date? | PW Medtech Group hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies PW Medtech Group has invested to date? | As of November 2026, PW Medtech Group has invested in 1 company. |
| What was the last PW Medtech Group investment? | On 24th August 2018 PW Medtech Group invested in Taibang Biological Group, participating in a $590M Undisclosed stage round, alongside Hillhouse Investment, Centurium Capital, and CITIC Capital Holdings. |
| In what companies PW Medtech Group invested in? | PW Medtech Group invested in Taibang Biological Group. |
Lists including PW Medtech Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.